共 50 条
TARGETING THE CD6-ALCAM T CELL COSTIMULATORY PATHWAY AFTER ALLOGENEIC CELL TRANSPLANTATION FOR ACUTE GRAFT VERSUS HOST DISEASE (AGVHD) TREATMENT USING ANTI-CD6 MONOCLONAL ANTIBODY ITOLIZUMAB
被引:0
|作者:
Rambaldi, B.
[1
,2
,3
]
Kim, H. T.
[4
]
Arihara, Y.
[1
,2
,5
]
Asano, T.
[1
,2
,6
]
Reynolds, C.
[1
,2
]
Manter, M.
[1
,2
]
Halpern, M.
[1
,2
]
Weber, A.
[1
,2
]
Koreth, J.
[1
,2
]
Cutler, C.
[1
,2
]
Gooptu, M.
[1
,2
]
Nikiforow, S.
[1
,2
]
Ho, V. T.
[1
,2
]
Antin, J. H.
[1
,2
]
Romee, R.
[1
,2
]
Ampudia, J.
[7
]
Ng, C.
[7
]
Connelly, S.
[7
]
Soiffer, R. J.
[1
,2
]
Ritz, J.
[1
,2
]
机构:
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Milao Bicocca, PhD Program Translat & Mol Med DIMET, Milan, Italy
[4] Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
[5] Sapporo Med Univ, Dept Med Oncol, Sapporo, Hokkaido, Japan
[6] Himeji Red Cross Hosp, Dept Hematol & Oncol, Himeji, Hyogo, Japan
[7] Equillium, San Diego, CA USA
来源:
关键词:
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
C70
引用
收藏
页码:55 / 55
页数:1
相关论文